The HudsonAlpha Institute for Biotechnology has added a new name to its roster of resident companies: Veil Genomics.

The startup, founded by HudsonAlpha geneticists Alex Harkess, PhD, Josh Clevenger, PhD, and Kendall Lee, PhD, focuses on genetic testing and informatics.

Veil offers end-to-end services in long-read, low-pass sequencing, a technology with wide applications in human health, agriculture, biodiversity research, and defense. It becomes the latest of more than 50 independent companies operating on HudsonAlpha’s biotech campus.

The idea to launch Veil emerged from a collaborative laboratory innovation between the three founders. Each has a deep understanding of long-read DNA sequencing, which empowered them to explore ways to speed up the process with high accuracy and scalability.

“We’ve redefined what it means to do long-read genome sequencing at scale,” said Alex Harkess, co-founder at Veil. “Our mission at Veil is to democratize the ability for anyone to create rapid impact in their field by harnessing the power of long-read PacBio HiFi sequencing to identify meaningful genetic variation faster than ever.”

Veil Genomics also represents a commercialization success story for HudsonAlpha. One of the Institute’s founding missions has been to translate discoveries out of the academic lab setting into applications that can be used by the people and organizations that need them most. Veil is the latest example of the innovation cultivated on HudsonAlpha’s campus that has broadened its reach to make a deeper impact.

“I’m thrilled to see Alex, Josh, and Kendall driving genomic innovation forward through the launch of Veil Genomics,” said Dillon Fritz, PhD, HudsonAlpha’s Vice President for Economic Development and Commercialization. “Their work is a testament to the groundbreaking science happening here at HudsonAlpha. As both a launchpad for translational research and a landing spot for life science ventures, HudsonAlpha provides the ecosystem and support needed to turn discovery into real-world impact. We are excited to welcome Veil as they build on their scientific excellence and contribute to the continued growth of our innovation community.”